SLAM
COLL icon

Swiss Life Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Swiss Life Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$253K Buy
+6,993
New +$239K ﹤0.01% 1382
2026
Q1 		– Sell
-4,650
Closed -$215K – 1532
2025
Q4 		$215K Buy
+4,650
New +$195K ﹤0.01% 1233

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Swiss Life Asset Management's COLL Position: Q2 2026 in Review

Swiss Life Asset Management opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 6,993 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #1382 among its holdings. This is a return to the name: Swiss Life Asset Management previously reported a position in COLL as recently as Q4 2025.

Swiss Life Asset Management first reported a position in COLL in Q4 2025 and has held it in 2 quarters since. 167 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Swiss Life Asset Management held 6,993 shares of Collegium Pharmaceutical worth $253K as of Q2 2026.
  • Collegium Pharmaceutical was a new Swiss Life Asset Management position in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1382 holding.
  • Swiss Life Asset Management first reported a position in Collegium Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • 167 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.